Skip to content
BOLUS

Signal from the log

Monocacy Therapeutics

125 000 $ · United States

Monocacy Therapeutics, à Monrovia dans le Maryland, a déposé trois formulaires D le même jour, pour des tranches de 125 000 et 150 000 dollars auprès de 5 puis 1 investisseur, et un amendement portant 114 450 dollars. Le dépôt se range en biotechnologie et ne nomme aucun fonds.

Spotted Amount read from the headline

Announced on , logged by the watch of 28 August 2026.

Operation
Funding round
Announced amount
125 000 $
Country
United States

What the log says

Editorial note, in French

Dépôt réglementaire repéré à la SEC. Le tour n'est pas encore documenté publiquement, aucun fonds n'y est nommé.

What is missing before publishing
  • No fund is publicly named. It is the first condition of the selection bar: without a named investor there is no round to tell.
  • The amount shown is an automatic reading of the source headline, not a reading of the press release. It is not verified yet.
  • The stage of the round is not disclosed. A letter is never inferred from an amount or a track record.
Provenance
Source edgar
Logged on 28 August 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification The fields shown come from an automatic reading of the source headline. They have not yet been checked against the press release and should not be quoted as verified.
What this status means
Spotted The collection saw this operation and logged it. Nobody has processed it yet, so what is shown is still an automatic reading of the source headline.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.

One address, nothing else.

One letter a week, on Fridays: the week's funding rounds, the funds named, the amounts double checked. The list is never sold, one click to unsubscribe. The letter is written in French.

Email confirmation before any subscription. The list is never sold. What Bolus knows about you is written on the privacy page (in French).